Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A effects on masticatory muscle structure and function in bruxism
TCTR20260921009Active, not recruiting
- Sponsor
- Akdeniz University
- Start
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in bruxism, sponsored by Akdeniz University. Primary endpoints: Muscle thickness, Apparent diffusion coefficient and 1 more. Started Jan 2024; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
bruxism
Beyond the preview
Go deeper on TCTR20260921009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260921009.